L’Oréal Issues Voluntary Recall of Benzoyl Peroxide Products Over Benzene Concerns

March 11, 2025

L’Oréal announced it is recalling all lots of its acne treatment Effaclar Duo in the U.S. due to concerns over benzene contamination. The product, sold under the La Roche-Posay brand, contains benzoyl peroxide (BPO).

Valisure, an independent testing laboratory, first reported benzene contamination in several BPO-containing acne products more than a year ago, urging the US Food and Drug Administration (FDA) to take action.

Read further analysis at Dermatology Times >>

Previous coverage of reports studying benzene presence in topical acne products formulated with benzoyl peroxide:

Topics in Article

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Merz Aesthetics’ Radiesse Receives FDA Approval for Décolleté Wrinkles
    • New Book “Get Found, Get Booked” Reveals a Smarter, Ethical Approach to Marketing for Med Spas and Wellness Practices
    • Growth, Capital and Control: Navigating Private Equity in Aesthetics
    • Med Spas Under the Microscope – The View From The FDA
    • Revance and Teoxane Announce RHA Dynamic Volume is Now Available